Clinical Trials Directory

Trials / Completed

CompletedNCT03302442

Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis

Status
Completed
Phase
Study type
Observational
Enrollment
3,000 (actual)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The aim of this observational study is to compare Dimethyl fumarate (DMF) and Teriflunomide on both clinical and MRI outcomes in patients with relapsing-remitting multiple sclerosis (RRMS) from French Observatory of Multiple Sclerosis (French MS cohort )

Conditions

Interventions

TypeNameDescription
OTHERNon interventional studyNot applicable - Non interventional Study

Timeline

Start date
2017-05-01
Primary completion
2017-08-01
Completion
2017-10-01
First posted
2017-10-05
Last updated
2017-10-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03302442. Inclusion in this directory is not an endorsement.